Total Debt
$1.8M
Net Debt
-$193M
Candel Therapeutics, Inc. currently has $1.8M in total debt. Net debt is -$193M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
CADL • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.19 | -0.19Net Cash | 0.20 | 0.9% |
| 2025-12-31 | 0.00 | 0.12 | -0.12Net Cash | 0.13 | 1.5% |
| 2025-09-30 | 0.01 | 0.09 | -0.08Net Cash | 0.09 | 6.7% |
| 2025-06-30 | 0.01 | 0.10 | -0.09Net Cash | 0.11 | 7.9% |
| 2025-03-31 | 0.01 | 0.09 | -0.08Net Cash | 0.10 | 11.4% |
| 2024-12-31 | 0.01 | 0.10 | -0.09Net Cash | 0.11 | 12.6% |
| 2024-09-30 | 0.02 | 0.02 | 0.00 | 0.02 | 77.0% |
| 2024-06-30 | 0.02 | 0.02 | -0.00Net Cash | 0.03 | 72.1% |
| 2024-03-31 | 0.02 | 0.03 | -0.00Net Cash | 0.03 | 67.5% |
| 2023-12-31 | 0.02 | 0.04 | -0.01Net Cash | 0.04 | 54.6% |
| 2023-09-30 | 0.02 | 0.04 | -0.02Net Cash | 0.05 | 45.5% |
| 2023-06-30 | 0.02 | 0.05 | -0.03Net Cash | 0.06 | 38.8% |
| 2023-03-31 | 0.02 | 0.06 | -0.04Net Cash | 0.07 | 33.9% |
| 2022-12-31 | 0.02 | 0.07 | -0.05Net Cash | 0.08 | 29.0% |
| 2022-09-30 | 0.02 | 0.08 | -0.05Net Cash | 0.09 | 26.8% |
| 2022-06-30 | 0.02 | 0.09 | -0.06Net Cash | 0.09 | 24.4% |
| 2022-03-31 | 0.02 | 0.09 | -0.07Net Cash | 0.10 | 22.4% |
| 2021-12-31 | 0.00 | 0.08 | -0.08Net Cash | 0.09 | 0.6% |
| 2021-09-30 | 0.00 | 0.09 | -0.09Net Cash | 0.10 | 0.6% |
| 2021-06-30 | 0.00 | 0.02 | -0.02Net Cash | 0.03 | 1.7% |
| 2021-03-31 | 0.00 | 0.03 | -0.03Net Cash | 0.04 | 2.8% |
| 2020-12-31 | 0.00 | 0.04 | -0.03Net Cash | 0.04 | 2.5% |